Discovering Associations of Adverse Events with Pharmacotherapy in Patients with Non-Small Cell Lung Cancer Using Modified Apriori Algorithm

Table 7

Meaningful association rules between adverse events and drug combination.

AE	Clinical laboratory	Drug	Comp	Support	Confidence
Anemia	HGB	Gemcitabine  +  carboplatin	13.74	1.33%	84.09%
Neutrophil count decreased	NEUT#	Gemcitabine + cisplatin	15.58	1.31%	73.27%
Alanine aminotransferase increased	ALT	Paclitaxel  +  gemcitabine	8.19	1.08%	56.74%
Aspartate aminotransferase increased	AST	Nedaplatin  +  pemetrexed	6.65	1.23%	39.22%
Hypoglycemia	GLU	Carboplatin  +  paclitaxel	6.16	5.42%	49.72%